Want to see BTSG full AI Analyst Report?
BTSG Stock Chart & Stats
$47.27
-$0.12(-0.69%)
At close: 4:00 PM EST
$47.27
-$0.12(-0.69%)
Day’s Range― - ―
52-Week Range$19.01 - $72.06
Previous CloseN/A
Volume351.53K
Average Volume (3M)3.65M
Market Cap
$13.85B
Enterprise Value$14.46B
Total Cash (Recent Filing)$888.80M
Total Debt (Recent Filing)$2.70B
Price to Earnings (P/E)46.2
Beta1.10
Next Earnings
Jul 31, 2026EPS Estimate
0.39Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.52
Shares Outstanding196,258,400
10 Day Avg. Volume4,124,720
30 Day Avg. Volume3,649,146
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)4.05
Price to Sales (P/S)0.59
P/FCF Ratio19.22
Enterprise Value/Market Cap1.04
Enterprise Value/Revenue1.06
Enterprise Value/Gross Profit8.70
Enterprise Value/Ebitda27.42
Forecast
1Y Price Target
$69.64Price Target Upside47.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
EPS Forecast (FY)1.7
Revenue Forecast (FY)$15.07B
Bulls Say, Bears Say
Bulls Say
Free Cash Flow StrengthSustained FCF near $500M provides durable internal funding for debt reduction, acquisitions, and working capital. Free cash flow roughly matching net income indicates high cash quality, improving financial flexibility and supporting deleveraging and reinvestment over the next several quarters.
Return To Profitability & Revenue GrowthRe-emergence of positive net income across a multi-year growth trend shows operational recovery and demand resilience. Steady revenue expansion with profitable operations improves long-term sustainability, enabling reinvestment and enhancing the firm's ability to withstand reimbursement or volume shocks.
Pharmacy Specialty, Infusion & Integration MomentumRapid specialty and infusion growth represents a higher-complexity, stickier revenue stream with better margin potential. Successful integration of Amedisys/LHC assets that add year‑1 EBITDA demonstrates scalable M&A capability and expands service footprint, strengthening structural competitive position.
Bears Say
Thin Profit MarginsLow absolute gross and EBITDA margins leave limited room to absorb higher labor, drug acquisition, or SG&A costs. Structural margin thinness constrains cash return on revenue and makes sustained profitability sensitive to reimbursement changes or execution shortfalls over the medium term.
Material Industry Headwinds (IRA & Generics)Quantified, multi-hundred-million revenue impacts from IRA and brand-to-generic shifts represent structural reimbursement and pricing pressure. These secular forces can erode core pharmacy revenue unless offset by diversification, higher-margin services, or scale efficiencies over multiple quarters.
Elevated Corporate InvestmentsSustained increases in IT, sales and corporate costs can weigh on margin expansion if incremental revenue and efficiency gains lag. Persistent elevated SG&A raises the break-even hurdle for acquisitions and organic growth, making medium-term margin improvement dependent on clear execution payoff.
BrightSpring Health Services, Inc. News
BTSG FAQ
What was BrightSpring Health Services, Inc.’s price range in the past 12 months?
BrightSpring Health Services, Inc. lowest stock price was $19.01 and its highest was $72.06 in the past 12 months.
What is BrightSpring Health Services, Inc.’s market cap?
BrightSpring Health Services, Inc.’s market cap is $13.85B.
When is BrightSpring Health Services, Inc.’s upcoming earnings report date?
BrightSpring Health Services, Inc.’s upcoming earnings report date is Jul 31, 2026 which is in 23 days.
How were BrightSpring Health Services, Inc.’s earnings last quarter?
BrightSpring Health Services, Inc. released its earnings results on May 01, 2026. The company reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.309 by $0.081.
Is BrightSpring Health Services, Inc. overvalued?
According to Wall Street analysts BrightSpring Health Services, Inc.’s price is currently Undervalued.
Does BrightSpring Health Services, Inc. pay dividends?
BrightSpring Health Services, Inc. does not currently pay dividends.
What is BrightSpring Health Services, Inc.’s EPS estimate?
BrightSpring Health Services, Inc.’s EPS estimate is 0.39.
How many shares outstanding does BrightSpring Health Services, Inc. have?
BrightSpring Health Services, Inc. has 196,258,400 shares outstanding.
What happened to BrightSpring Health Services, Inc.’s price movement after its last earnings report?
BrightSpring Health Services, Inc. reported an EPS of $0.39 in its last earnings report, beating expectations of $0.309. Following the earnings report the stock price went up 9.61%.
Which hedge fund is a major shareholder of BrightSpring Health Services, Inc.?
Currently, no hedge funds are holding shares in BTSG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
BrightSpring Health Services, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$69.64 (47.32% Upside)
$69.64 (47.32% Upside)
Blogger Sentiment
Bullish
BTSG Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.5M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.7B over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.4%
Last 30 Days ▲ 19.2%
Last 30 Days ▲ 19.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
218.98%
12-Months-Change
Fundamentals
Return on Equity
12.71%
Trailing 12-Months
Asset Growth
6.27%
Trailing 12-Months
Company Description
BrightSpring Health Services, Inc.
BrightSpring Health Services, Inc. operates across the United States, offering a range of healthcare solutions directly within patients' homes and local communities. The company's extensive platform focuses on providing crucial pharmacy and medical provider services, including both clinical care and supportive assistance, to individuals covered by Medicare, Medicaid, and private insurance. Patients receive care from a dedicated team of clinical professionals and licensed pharmacists. Formerly known as Phoenix Parent Holdings Inc., the company officially adopted the name BrightSpring Health Services, Inc. in May 2021. Founded in 1974, its headquarters are located in Louisville, Kentucky.
BTSG Company Deck
BTSG Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented strong operational and financial momentum: double-digit revenue growth, a 45% increase in adjusted EBITDA, improved margins, solid segment performance in specialty, infusion and home health, successful integration contributions, and a meaningful cash proceeds event to strengthen the balance sheet. These positives are tempered by clear, quantified headwinds from IRA impacts and brand-to-generic conversions (~$600M aggregate headwind referenced), a Q1 rise in corporate investments, and ongoing PBM/payer competitive dynamics. Management characterized the headwinds as expected and actionable and reiterated guidance, suggesting confidence in execution and mitigation plans.View all BTSG earnings summariesBTSG Stock 12 Month Forecast
Average Price Target
$69.64
▲(47.32% Upside)
Technical Analysis
Ownership Overview
28.41% Insiders
31.70% Mutual Funds
0.03% Other Institutional Investors
17.19% Public Companies and Individual Investors